# Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.

> **NCT05534399** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 526 (estimated)

## Conditions studied

- Urinary Tract Disease

## Interventions

- **PROCEDURE:** Intra-vesical BoNTA injections

## Key facts

- **NCT ID:** NCT05534399
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 526 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05534399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05534399, "Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05534399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*